Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple nutrient supplement boost malaria protection in kids?

NCT ID NCT06599593

Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding a daily nutrient supplement (SQ-LNS) to monthly malaria prevention visits can reduce both malaria and malnutrition in children aged 6-24 months in Burkina Faso. Researchers will compare malaria rates and nutritional status between children receiving the supplement plus standard care versus standard care alone. The goal is to see if combining these interventions on the existing seasonal malaria chemoprevention platform is feasible and effective.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Small Quantity Lipid-Based Nutrient Supplement (SQ-LNS)
What this could lead to
If successful, this could show that combining nutrition with malaria prevention on the same platform reduces both diseases more effectively than malaria prevention alone.
What could go wrong
This is a small pilot study (438 children) in one region, so results may not apply elsewhere. Adding supplements may not significantly improve outcomes and could complicate delivery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

438 people

The number who actually took part.

Started

Jul 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 59 months

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Children will be eligible for inclusion in the trial if they meet all of the following criteria: * Live in the study community * Eligible for SMC * No allergy to peanuts or cow's milk * Able to orally feed * Within the eligible age ranges: * 6-59 months for passive surveillance * 6-24 months for SQ-LNS provision * Written informed consent from at least one caregiver * Caregiver is at least 18 years of age Children will be recruited during normal distribution (via door-to-door delivery) for SMC, which occurs monthly during the malaria season (July through October). Children ages 3-6 months are eligible for SMC and will be included in nutritional screening and monitoring by default but will not be eligible for SQ-LNS, which is designed for children ages 6-24 months and will not be part of the passive surveillance. A random sample of children ages 6-24 months during the first month of distribution will be asked to participate in an active surveillance cohort. These children will be followed biweekly for screening for malaria with a rapid diagnostic test and temperature and monthly for dried blood spot and anthropometric measurements.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acute malnutrition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

malaria nutritional deficiency disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acute malnutrition Acute malnutrition in childhood Integrated community-based intervention package Malaria incidence Nutrition assessment Seasonal malaria chemoprevention

Contacts and locations

Locations

  • Centre de Recherche en Sante de Nouna

    Nouna, Burkina Faso

More trials for these conditions

Other studies related to the condition(s) this trial covers.